{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:06:51Z","timestamp":1791875211621,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Seventh Cycle Clinical Key (Cultivation) Specialty in Hefei Department Construction Project","award":["No. Z033-1"],"award-info":[{"award-number":["No. Z033-1"]}]},{"name":"Seventh Cycle Clinical Key (Cultivation) Specialty in Hefei Department Construction Project","award":["No. Z033-1"],"award-info":[{"award-number":["No. Z033-1"]}]},{"name":"Seventh Cycle Clinical Key (Cultivation) Specialty in Hefei Department Construction Project","award":["No. Z033-1"],"award-info":[{"award-number":["No. Z033-1"]}]},{"name":"Seventh Cycle Clinical Key (Cultivation) Specialty in Hefei Department Construction Project","award":["No. Z033-1"],"award-info":[{"award-number":["No. Z033-1"]}]},{"name":"Seventh Cycle Clinical Key (Cultivation) Specialty in Hefei Department Construction Project","award":["No. Z033-1"],"award-info":[{"award-number":["No. Z033-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10995-3","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:08:29Z","timestamp":1746533309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between gut microbiota in HIV-infected patients and immune reconstitution following antiretroviral therapy (ART)"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuru","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"10995_CR1","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1097\/CM9.0000000000001842","volume":"134","author":"JJ Xu","year":"2021","unstructured":"Xu JJ, Han MJ, Jiang YJ, et al. Prevention and control of HIV\/AIDS in China: lessons from the past three decades. Chin Med J (Engl). 2021;134:2799\u2013809.","journal-title":"Chin Med J (Engl)"},{"key":"10995_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13073-024-01336-1","volume":"16","author":"K Luo","year":"2024","unstructured":"Luo K, Peters BA, Moon JY, et al. Metabolic and inflammatory perturbation of diabetes associated gut dysbiosis in people living with and without HIV infection. Genome Med. 2024;16:59.","journal-title":"Genome Med"},{"key":"10995_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40168-023-01566-2","volume":"11","author":"Z Wang","year":"2023","unstructured":"Wang Z, Peters BA, Bryant M, et al. Gut microbiota, Circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection. Microbiome. 2023;11:119.","journal-title":"Microbiome"},{"key":"10995_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3748\/wjg.v27.i1.107","volume":"27","author":"ES Rahayu","year":"2021","unstructured":"Rahayu ES, Mariyatun M, Putri Manurung NE, et al. Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults. World J Gastroenterol. 2021;27:107\u201328.","journal-title":"World J Gastroenterol"},{"key":"10995_CR5","doi-asserted-by":"publisher","first-page":"1297378","DOI":"10.3389\/fimmu.2023.1297378","volume":"14","author":"J Mart\u00ednez-Sanz","year":"2023","unstructured":"Mart\u00ednez-Sanz J, Talavera-Rodr\u00edguez A, D\u00edaz-\u00c1lvarez J, et al. A gut Microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease. Front Immunol. 2023;14:1297378.","journal-title":"Front Immunol"},{"key":"10995_CR6","doi-asserted-by":"publisher","first-page":"113336","DOI":"10.1016\/j.celrep.2023.113336","volume":"42","author":"I Sereti","year":"2023","unstructured":"Sereti I, Verburgh ML, Gifford J, et al. Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV. Cell Rep. 2023;42:113336.","journal-title":"Cell Rep"},{"key":"10995_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40168-024-01925-7","volume":"12","author":"C Boukadida","year":"2024","unstructured":"Boukadida C, Peralta-Prado A, Ch\u00e1vez-Torres M, et al. Alterations of the gut Microbiome in HIV infection highlight human anelloviruses as potential predictors of immune recovery. Microbiome. 2024;12:204.","journal-title":"Microbiome"},{"key":"10995_CR8","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1038\/s41598-022-06532-w","volume":"12","author":"S Ngcobo","year":"2022","unstructured":"Ngcobo S, Molatlhegi RP, Osman F, et al. Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression. Sci Rep. 2022;12:2437.","journal-title":"Sci Rep"},{"key":"10995_CR9","doi-asserted-by":"publisher","first-page":"947647","DOI":"10.3389\/fimmu.2022.947647","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wei Y, Wang D, et al. Elevated Foxp3\u2009+\u2009double-negative T cells are associated with disease progression during HIV infection. Front Immunol. 2022;13:947647.","journal-title":"Front Immunol"},{"key":"10995_CR10","doi-asserted-by":"publisher","first-page":"109344","DOI":"10.1016\/j.celrep.2021.109344","volume":"36","author":"Y Fu","year":"2021","unstructured":"Fu Y, Zhang Z, Yang Z, et al. CD27-CD38\u2009+\u2009B cells accumulated in early HIV infection exhibit transitional profile and promote HIV disease progression. Cell Rep. 2021;36:109344.","journal-title":"Cell Rep"},{"key":"10995_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/QAI.0000000000002817","volume":"89","author":"MH Meyer-Myklestad","year":"2022","unstructured":"Meyer-Myklestad MH, Medhus AW, Stiksrud B, et al. Probiotics to HIV-infected immunological nonresponders: altered mucosal immunity and microbial diversity restricted to ileum. J Acquir Immune Defic Syndr. 2022;89:77\u201386.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10995_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/infdis\/jiaa714","volume":"225","author":"MH Meyer-Myklestad","year":"2022","unstructured":"Meyer-Myklestad MH, Medhus AW, Lorvik KB, et al. Human immunodeficiency virus-infected immunological nonresponders have colon-restricted gut mucosal immune dysfunction. J Infect Dis. 2022;225:661\u201374.","journal-title":"J Infect Dis"},{"key":"10995_CR13","doi-asserted-by":"publisher","first-page":"104382","DOI":"10.1016\/j.ebiom.2022.104382","volume":"86","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Yan L, Han J, et al. Metabolism-dependent ferroptosis promotes mitochondrial dysfunction and inflammation in CD4\u2009+\u2009T lymphocytes in HIV-infected immune non-responders. EBioMedicine. 2022;86:104382.","journal-title":"EBioMedicine"},{"key":"10995_CR14","doi-asserted-by":"publisher","first-page":"e1011824","DOI":"10.1371\/journal.ppat.1011824","volume":"19","author":"L Ling","year":"2023","unstructured":"Ling L, De C, Spagnuolo RA, et al. Transient CD4+ T cell depletion during suppressive ART reduces the HIV reservoir in humanized mice. PLoS Pathog. 2023;19:e1011824.","journal-title":"PLoS Pathog"},{"key":"10995_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12981-021-00389-1","volume":"18","author":"H Payne","year":"2021","unstructured":"Payne H, Chan MK, Watters SA, et al. Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial. AIDS Res Ther. 2021;18:63.","journal-title":"AIDS Res Ther"},{"key":"10995_CR16","doi-asserted-by":"publisher","first-page":"e0070821","DOI":"10.1128\/Spectrum.00708-21","volume":"9","author":"A Ishizaka","year":"2021","unstructured":"Ishizaka A, Koga M, Mizutani T, et al. Unique gut Microbiome in HIV patients on antiretroviral therapy (ART) suggests association with chronic inflammation. Microbiol Spectr. 2021;9:e0070821.","journal-title":"Microbiol Spectr"},{"key":"10995_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.62.12.1","volume":"62","author":"Q Liu","year":"2021","unstructured":"Liu Q, Xu ZY, Wang XL, et al. Changes in conjunctival microbiota associated with HIV infection and antiretroviral therapy. Invest Ophthalmol Vis Sci. 2021;62:1.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10995_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00005-021-00616-7","volume":"69","author":"E Jab\u0142onowska","year":"2021","unstructured":"Jab\u0142onowska E, Strzelczyk J, Piekarska A, et al. Gut microbiota diversity in HIV-infected patients on successful antiretroviral treatment is linked to sexual preferences but not CD4 nadir. Arch Immunol Ther Exp (Warsz). 2021;69:14.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10995_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41598-020-80247-8","volume":"11","author":"M Imahashi","year":"2021","unstructured":"Imahashi M, Ode H, Kobayashi A, et al. Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients. Sci Rep. 2021;11:960.","journal-title":"Sci Rep"},{"key":"10995_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40168-024-01758-4","volume":"12","author":"S Singh","year":"2024","unstructured":"Singh S, Giron LB, Shaikh MW, et al. Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging. Microbiome. 2024;12:31.","journal-title":"Microbiome"},{"key":"10995_CR21","doi-asserted-by":"publisher","first-page":"104286","DOI":"10.1016\/j.ebiom.2022.104286","volume":"84","author":"JA Fulcher","year":"2022","unstructured":"Fulcher JA, Li F, Tobin NH, et al. Gut dysbiosis and inflammatory blood markers precede HIV with limited changes after early seroconversion. EBioMedicine. 2022;84:104286.","journal-title":"EBioMedicine"},{"key":"10995_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fimmu.2016.00404","volume":"7","author":"M Hoenigl","year":"2016","unstructured":"Hoenigl M, P\u00e9rez-Santiago J, Nakazawa M, et al. (1\u21923)-\u03b2-d-Glucan: a biomarker for microbial translocation in individuals with acute or early HIV infection? Front Immunol. 2016;7:404.","journal-title":"Front Immunol"},{"key":"10995_CR23","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1021\/acsinfecdis.0c00536","volume":"7","author":"S Ray","year":"2021","unstructured":"Ray S, Narayanan A, Giske CG, et al. Altered gut Microbiome under antiretroviral therapy: impact of Efavirenz and Zidovudine. ACS Infect Dis. 2021;7:1104\u201315.","journal-title":"ACS Infect Dis"},{"key":"10995_CR24","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3389\/fmicb.2018.01451","volume":"9","author":"W Lu","year":"2018","unstructured":"Lu W, Feng Y, Jing F, et al. Association between gut microbiota and CD4 recovery in HIV-1 infected patients. Front Microbiol. 2018;9:1451.","journal-title":"Front Microbiol"},{"key":"10995_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ebiom.2016.04.033","volume":"8","author":"S Serrano-Villar","year":"2016","unstructured":"Serrano-Villar S, Rojo D, Mart\u00ednez-Mart\u00ednez M, et al. Gut bacteria metabolism impacts immune recovery in HIV-infected individuals. EBioMedicine. 2016;8:203\u201316.","journal-title":"EBioMedicine"},{"key":"10995_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s12879-021-06491-z","volume":"21","author":"D Lu","year":"2021","unstructured":"Lu D, Zhang JB, Wang YX, et al. Association between CD4\u2009+\u2009T cell counts and gut microbiota and serum cytokines levels in HIV-infected immunological non-responders. BMC Infect Dis. 2021;21:742.","journal-title":"BMC Infect Dis"},{"key":"10995_CR27","doi-asserted-by":"publisher","first-page":"2164448","DOI":"10.1080\/19490976.2022.2164448","volume":"15","author":"M Vallier","year":"2023","unstructured":"Vallier M, Suwandi A, Ehrhardt K, et al. Pathometagenomics reveals susceptibility to intestinal infection by Morganella to be mediated by the blood group-related B4galnt2 gene in wild mice. Gut Microbes. 2023;15:2164448.","journal-title":"Gut Microbes"},{"key":"10995_CR28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/jac\/dkad037","volume":"78","author":"B Lu","year":"2023","unstructured":"Lu B, Wong M, Ha D, et al. Piperacillin\/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients. J Antimicrob Chemother. 2023;78:1009\u201314.","journal-title":"J Antimicrob Chemother"},{"key":"10995_CR29","doi-asserted-by":"publisher","first-page":"e24399","DOI":"10.1002\/jcla.24399","volume":"36","author":"H Shi","year":"2022","unstructured":"Shi H, Chen X, Yao Y, et al. Morganella Morganii: an unusual analysis of 11 cases of pediatric urinary tract infections. J Clin Lab Anal. 2022;36:e24399.","journal-title":"J Clin Lab Anal"},{"key":"10995_CR30","doi-asserted-by":"publisher","first-page":"107323","DOI":"10.1016\/j.phrs.2024.107323","volume":"207","author":"L Lin","year":"2024","unstructured":"Lin L, Tang R, Liu Y, et al. The brain-protective mechanism of fecal microbiota transplantation from young donor mice in the natural aging process via exosome, gut microbiota, and metabolomics analyses. Pharmacol Res. 2024;207:107323.","journal-title":"Pharmacol Res"},{"key":"10995_CR31","doi-asserted-by":"publisher","first-page":"13803","DOI":"10.3390\/ijms241813803","volume":"24","author":"J Su","year":"2023","unstructured":"Su J, Guan B, Su Q, et al. Fucoxanthin ameliorates sepsis via modulating microbiota by targeting IRF3 activation. Int J Mol Sci. 2023;24:13803.","journal-title":"Int J Mol Sci"},{"key":"10995_CR32","doi-asserted-by":"publisher","first-page":"1204273","DOI":"10.3389\/fmolb.2023.1204273","volume":"10","author":"LG G\u00f3mez-Archila","year":"2023","unstructured":"G\u00f3mez-Archila LG, Palomino-Sch\u00e4tzlein M, Zapata-Builes W, et al. Plasma metabolomics by nuclear magnetic resonance reveals biomarkers and metabolic pathways associated with the control of HIV-1 infection\/progression. Front Mol Biosci. 2023;10:1204273.","journal-title":"Front Mol Biosci"},{"key":"10995_CR33","doi-asserted-by":"publisher","first-page":"885386","DOI":"10.3389\/fphar.2022.885386","volume":"13","author":"D Lao","year":"2022","unstructured":"Lao D, Liu R, Liang J. Study on plasma metabolomics for HIV\/AIDS patients treated by HAART based on LC\/MS-MS. Front Pharmacol. 2022;13:885386.","journal-title":"Front Pharmacol"},{"key":"10995_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2989\/16085906.2022.2087532","volume":"21","author":"I Ezenwosu","year":"2022","unstructured":"Ezenwosu I, Ezenwosu O, Mbachu C, et al. Effect of nutrition education on nutritional status and serum zinc level of HIV and AIDS clients: implication for care in resource-limited settings. Afr J AIDS Res. 2022;21:270\u20136.","journal-title":"Afr J AIDS Res"},{"key":"10995_CR35","doi-asserted-by":"publisher","first-page":"1254155","DOI":"10.3389\/fimmu.2023.1254155","volume":"14","author":"L Lu","year":"2023","unstructured":"Lu L, Yang Y, Yang Z, et al. Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy. Front Immunol. 2023;14:1254155.","journal-title":"Front Immunol"},{"key":"10995_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biochi.2022.04.002","volume":"199","author":"S Chandel","year":"2022","unstructured":"Chandel S, Joon A, Ghosh S. Enteroaggregative Escherichia coli induces altered glycosylation in membrane proteins of cultured human intestinal epithelial cells. Biochimie. 2022;199:68\u201380.","journal-title":"Biochimie"},{"key":"10995_CR37","doi-asserted-by":"publisher","first-page":"114206","DOI":"10.1016\/j.celrep.2024.114206","volume":"43","author":"A Singh","year":"2024","unstructured":"Singh A, Beaupre M, Villegas-Novoa C, et al. IL-22 promotes mucin-type O-glycosylation and MATH1\u2009+\u2009cell-mediated amelioration of intestinal inflammation. Cell Rep. 2024;43:114206.","journal-title":"Cell Rep"},{"key":"10995_CR38","doi-asserted-by":"publisher","first-page":"2152307","DOI":"10.1080\/19490976.2022.2152307","volume":"14","author":"P Paone","year":"2022","unstructured":"Paone P, Suriano F, Jian C, et al. Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion. Gut Microbes. 2022;14:2152307.","journal-title":"Gut Microbes"},{"key":"10995_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1186\/s12967-023-04687-2","volume":"21","author":"J Wei","year":"2023","unstructured":"Wei J, Chen C, Feng J, et al. Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway. J Transl Med. 2023;21:793.","journal-title":"J Transl Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10995-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:08:30Z","timestamp":1746533310000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10995-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10995"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10995-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was performed according to the Declaration of Helsinki or relevant guidelines and regulations, and was approved by the Ethics committee of First Affiliated Hospital of USTC (No. 2024RE284). This study has obtained the written informed consent forms provided by all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"666"}}